z-logo
open-access-imgOpen Access
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT
Author(s) -
Cristina Papayannidis,
Vincenzo Federico,
Luana Fianchi,
Patrizia Pregno,
Novella Pugliese,
Alessandra Romano,
Federica Irene Grifoni
Publication year - 2022
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2022.073
Subject(s) - midostaurin , medicine , systemic mastocytosis , intensive care medicine , discontinuation , adverse effect , apremilast , targeted therapy , maintenance therapy , oncology , disease , chemotherapy , leukemia , cancer , psoriatic arthritis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom